Bioreactor Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Bioreactor Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


Market Overview:

The global bioreactor market size reached US$ 6.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.2 Billion by 2028, exhibiting a growth rate (CAGR) of 12.1% during 2023-2028.

A bioreactor refers to a fermentation vessel, wherein biological reactions are executed for developing enzymes and various organisms, including bacteria, animal cells and yeast, under controlled conditions. It aids in producing several pharmaceuticals, such as vaccines and monoclonal antibodies, maintaining the inhomogeneous state of the cells to obtain the desired output, and monitoring the environmental conditions for promoting the cell formation process. On account of these properties, a bioreactor is extensively used by biopharmaceutical companies, research and development (R&D) institutions, and contract research organizations (CROs). At present, it is commercially available in glass, stainless steel, and single-use material types.

Bioreactor Market Trends:



The global bioreactor market is majorly driven by the increasing prevalence of various chronic diseases, such as cancer and diabetes, especially amongst the steadily rising geriatric population. In line with this, the growing need for preventive vaccines, particularly during the sudden outbreak of the coronavirus disease (COVID-19) pandemic, have prompted several pharmaceutical companies to considerably invest in research and development (R&D) activities to extend their production capacities. This, in turn, is inflating the overall sales of bioreactors across the globe. Additionally, significant technological advancements, such as the introduction of single-use bioreactors (SUBs) for optimizing the quality, flexibility, and scalability of microorganisms’ formation operations with minimal cost and energy requirements, are positively stimulating the market growth. Apart from this, increasing biopharmaceuticals manufacturing capacities across developing nations, along with the rising demand for bioreactors that support modern, evolving, high-cell density, and intensified clinical processes requiring high oxygen transfer and great carbon dioxide (CO2) removal are propelling the market growth. Other factors, such as rapid expansion in the pharmaceutical and biologics sectors, the escalating need for effective treatment drugs, and the increasing awareness among consumers regarding the formulation and availability of personalized medicines, are contributing to the market growth significantly.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bioreactor market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, usage, scale and control type.

Breakup by Type:

Glass
Stainless Steel
Single-Use

Breakup by Usage:

Lab-Scale Production
Pilot-Scale Production
Full-Scale Production

Breakup by Scale:

5L-20L
20L-200L
200L-1500L
Above 1500L

Breakup by Control Type:

Manual
Automated

Breakup by Region:

North America

United States
Canada

Asia-Pacific

China
Japan
India
South Korea
Australia
Indonesia
Others

Europe

Germany
France
United Kingdom
Italy
Spain
Russia
Others

Latin America

Brazil
Mexico
Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 2mag AG, bbi-biotech GmbH, Bioengineering AG, Eppendorf SE, Getinge AB, Infors AG, Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, Solaris Biotechnology Srl and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

What was the size of the global bioreactor market in 2022?

What is the expected growth rate of the global bioreactor market during 2023-2028?

What are the key factors driving the global bioreactor market?

What has been the impact of COVID-19 on the global bioreactor market?

What is the breakup of the global bioreactor market based on the type?

What is the breakup of the global bioreactor market based on the usage?

What is the breakup of the global bioreactor market based on the control type?

What are the key regions in the global bioreactor market?

Who are the key players/companies in the global bioreactor market?


1 Preface
2 Scope and Methodology
  2.1 Objectives of the Study
  2.2 Stakeholders
  2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
  2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
  2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
  4.1 Overview
  4.2 Key Industry Trends
5 Global Bioreactor Market
  5.1 Market Overview
  5.2 Market Performance
  5.3 Impact of COVID-19
  5.4 Market Forecast
6 Market Breakup by Type
  6.1 Glass
6.1.1 Market Trends
6.1.2 Market Forecast
  6.2 Stainless Steel
6.2.1 Market Trends
6.2.2 Market Forecast
  6.3 Single-Use
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Usage
  7.1 Lab-Scale Production
7.1.1 Market Trends
7.1.2 Market Forecast
  7.2 Pilot-Scale Production
7.2.1 Market Trends
7.2.2 Market Forecast
  7.3 Full-Scale Production
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Scale
  8.1 5L-20L
8.1.1 Market Trends
8.1.2 Market Forecast
  8.2 20L-200L
8.2.1 Market Trends
8.2.2 Market Forecast
  8.3 200L-1500L
8.3.1 Market Trends
8.3.2 Market Forecast
  8.4 Above 1500L
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Control Type
  9.1 Manual
9.1.1 Market Trends
9.1.2 Market Forecast
  9.2 Automated
9.2.1 Market Trends
9.2.2 Market Forecast
10  Market Breakup by Region
  10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
  10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
  10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
  10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
  10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11  SWOT Analysis
  11.1 Overview
  11.2 Strengths
  11.3 Weaknesses
  11.4 Opportunities
  11.5 Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis
  13.1 Overview
  13.2 Bargaining Power of Buyers
  13.3 Bargaining Power of Suppliers
  13.4 Degree of Competition
  13.5 Threat of New Entrants
  13.6 Threat of Substitutes
14  Price Analysis
15  Competitive Landscape
  15.1 Market Structure
  15.2 Key Players
  15.3 Profiles of Key Players
15.3.1 2mag AG
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 bbi-biotech GmbH
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Bioengineering AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Eppendorf SE
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Getinge AB
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Infors AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Pall Corporation (Danaher Corporation)
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Sartorius AG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Solaris Biotechnology Srl
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Thermo Fisher Scientific Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings